• Home
  • Shop
  • About
  • FAQ
  • Contact
  • Compare Peptides
  • Wholesale
  • Where to Buy CJC-1295 for Research (2026 Guide)

    Research Use Only β€” Informational Content: The information in this article is intended for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Iron Peak Peptides products are strictly for laboratory and scientific research β€” not for human consumption. Consult a licensed healthcare provider before starting any treatment or therapy. These statements have not been evaluated by the FDA.

    Where to Buy CJC 1295 Research (2026 Guide)

    Where to Buy CJC-1295 for Research (2026 Guide)

    As preclinical growth hormone research continues to advance, CJC-1295 has emerged as one of the most studied synthetic growth hormone-releasing hormone (GHRH) analogs available to the scientific community. As a long-acting GHRH analog, CJC-1295 is widely used in laboratory studies and preclinical studies to investigate biological processes related to growth hormone regulation, including secretion dynamics, GHRH receptor binding kinetics, and peptide stability in controlled experimental models. Researchers sourcing this peptide for laboratory use face a crowded marketplace with wildly variable quality standards. Selecting the right supplier is as critical as the research design itself.

    This guide is intended strictly for licensed researchers and scientific professionals seeking to buy CJC-1295 intended solely for legitimate laboratory and preclinical research purposes. All content herein references preclinical and in vitro research contexts. CJC-1295 is not approved for human use, is not a dietary supplement, and is not intended to diagnose, treat, cure, or prevent any disease.

    What Is CJC-1295?

    CJC-1295 is a synthetic GHRH analog of growth hormone-releasing hormone (GHRH), a 29-amino-acid peptide that stimulates the anterior pituitary to release growth hormone. As a synthetic GHRH analog, CJC-1295 features a modified peptide structure designed to potentially improve resistance to enzymatic degradation, enhancing its stability and duration of action. First described in published literature in the early 2000s, CJC-1295 was engineered to improve upon the short half-life of endogenous GHRH(1–29), which is rapidly degraded by dipeptidyl peptidase IV (DPP-IV) enzymes in vivo.

    Researchers have noted that CJC-1295 incorporates specific amino acid substitutions at positions 2, 8, 15, and 27 to confer greater DPP-IV resistance, resulting in a significantly extended plasma half-life compared to native GHRH in preclinical models. CJC-1295 interacts with the GHRH receptor protein on somatotroph cells in the pituitary gland, initiating signaling pathways that stimulate growth hormone release. Notably, CJC-1295 DAC is a modified version that includes a Drug Affinity Complex (DAC), which enhances its pharmacokinetics and prolongs its half-life to approximately 8 days, compared to the shorter half-life of CJC-1295 without DAC (about 30 minutes). CJC-1295 DAC is designed to mimic the action of GHRH and is believed to increase endogenous growth hormone production, while the no DAC version may have a more immediate but shorter duration of action. This characteristic makes it a valuable compound for studies examining sustained growth hormone axis stimulation over longer experimental windows.

    CJC-1295 in Research Literature

    Research shows that preclinical studies published across multiple peer-reviewed journals have examined CJC-1295’s ability to dose-dependently increase plasma growth hormone levels and insulin-like growth factor (IGF-1) concentrations in animal models, with an apparent increase in lean mass observed. CJC-1295 has been suggested to promote the release of growth hormone (GH) in a pulsatile manner, potentially leading to improved muscle development and lean body mass. Studies have shown that CJC-1295 can increase plasma concentrations of GH by 2-3 fold for up to 6 days and IGF-1 levels by 1.5-3 fold for about 11 days, indicating its potential to enhance muscle mass and recovery. Its extended action profile allows researchers to design experiments with less frequent administration intervals, a practical advantage in longitudinal animal model research.

    CJC-1295 No DAC vs. CJC-1295 With DAC: Key Differences for Researchers

    One of the most common points of confusion when researchers look to buy CJC-1295 no DAC or the DAC variant is understanding what distinguishes these two forms at the molecular level. The addition of DAC (Drug Affinity Complex) alters the peptide structure, resulting in a longer half life for CJC-1295 DAC compared to the no DAC version. This structural modification improves resistance to enzymatic degradation and extends the peptide’s stability and biological activity, which can be critical for sustained hormone release in research settings.

    Research has also examined the effects of CJC-1295 on body composition, showing that peptide therapy may promote lean body mass and muscle development. Notably, studies in animal models indicate that CJC-1295 administration can lead to increases in body weight and length, suggesting a positive growth response in GH-deficient conditions.

    CJC-1295 With DAC (Drug Affinity Complex)

    CJC-1295 DAC is a long-acting GHRH analog that incorporates a maleimidopropionic acid (MPA) Drug Affinity Complex, enabling covalent binding to endogenous albumin following reconstitution. Preclinical studies have focused on the molecular interactions between CJC-1295 DAC and the receptor’s structure, examining how these interactions affect peptide stability and growth hormone signaling pathways. The mechanism of action involves activation of G-proteins upon binding to the GHRH receptor, which stimulates the production of secondary messengers like cyclic adenosine monophosphate (cAMP) and leads to phosphorylation of transcription factors that regulate GH gene expression. This albumin-binding mechanism dramatically extends the compound’s half-life in animal modelsβ€”published preclinical data suggests plasma half-lives measured in days rather than minutes. Researchers studying prolonged GH axis activation with infrequent dosing intervals in animal models often select this variant.

    CJC-1295 No DAC (Modified GRF 1-29)

    CJC-1295 without the DAC modificationβ€”often called Modified GRF(1-29) or Mod GRFβ€”retains the DPP-IV resistant amino acid substitutions but lacks the albumin-binding complex. As a result, its half-life in animal models is considerably shorter, making it ideal for research into pulsatile secretion and growth hormone regulation, as it supports studies that require GH secretion patterns closely mirroring natural physiological rhythms. Researchers investigating acute GH release dynamics frequently choose CJC-1295 no DAC for sale from verified suppliers for these protocols.

    Combination Research: CJC-1295 With Ipamorelin

    In the preclinical research community, CJC-1295 (no DAC) is frequently studied in combination with Ipamorelin, a selective growth hormone secretagogue that acts on ghrelin receptors. These studies are conducted in research models to evaluate the combined effects of a GHRH analog with a GHS-R agonist, which have been shown to produce synergistic effects on GH pulse amplitude in animal models. Some studies also measure gh mRNA levels to assess the impact of these peptides on growth hormone gene expression and hormonal activity. This has made the option to buy ipamorelin CJC-1295 as a pre-blended compound increasingly popular among peptide researchers looking to streamline experimental preparation.

    What Researchers Should Look for in a CJC-1295 Supplier

    The peptide research supply market is poorly regulated, and product quality can vary substantially between vendors. Before placing an order, researchers should evaluate potential suppliers against a rigorous set of quality benchmarks. Independent testing by accredited laboratories is essential for credibility and reliability, ensuring that research-grade peptides, including CJC-1295, meet the highest standards. Below are the non-negotiable criteria that distinguish a trustworthy source from an unreliable one.

    1. HPLC-Verified Purity of β‰₯98%

    High-performance liquid chromatography (HPLC) is the gold standard for assessing peptide purity. A reputable supplier will provide HPLC chromatograms confirming that CJC-1295 purity meets or exceeds 98%. Impure peptides introduce confounding variables that can compromise experimental reproducibility and data integrity. Any supplier unwilling or unable to provide HPLC data should be disqualified immediately.

    2. Third-Party quality assurance

    An independent, third-party quality assurance verifies that quality claims are not self-reported by the vendor. The quality assurance should confirm identity (via mass spectrometry), purity (via HPLC), and ideally moisture content or residual solvent levels. Researchers should always request and review the quality assurance before purchaseβ€”legitimate suppliers make these documents freely available.

    3. Lyophilized Powder Format

    Peptides intended for research use should be supplied in lyophilized (freeze-dried) powder form. Lyophilization removes moisture, dramatically improving stability and shelf life when properly stored. Liquid-form peptides are significantly more susceptible to degradation, and suppliers offering pre-dissolved peptides should be approached with skepticism unless the researcher has specific short-term experimental needs.

    4. US-Based Manufacturing and Shipping

    For researchers based in the United States, sourcing from a domestic supplier offers meaningful advantages: faster shipping times, lower risk of customs-related delays or seizures, and greater accountability under US consumer protection frameworks. Overseas suppliers may offer lower prices but frequently compromise on quality controls, documentation standards, and shipping reliability.

    5. Transparent Labeling and Batch Traceability

    Each vial should be clearly labeled with the peptide name, molecular weight, batch number, quantity (in mg), and storage recommendations. Batch traceability allows researchers to correlate experimental outcomes with specific production lotsβ€”an essential practice in rigorous scientific work.


    Why Iron Peak Peptides for CJC-1295 Research Supply

    Iron Peak Peptides is a US-based peptide research supplier committed to providing the scientific community with rigorously tested, high-purity compounds. Every batch undergoes HPLC and mass spectrometry verification, with third-party COAs available for review prior to purchase. Researchers looking to buy CJC peptide with confidence will find that Iron Peak Peptides meets all the criteria outlined above.

    All products are supplied as lyophilized powder in sealed, laboratory-grade vials and shipped from within the United States. Iron Peak Peptides does not market or sell compounds for human consumptionβ€”products are strictly for licensed research professionals and laboratory use.


    CJC-1295 Products Available for Research

    Iron Peak Peptides currently offers the following CJC-1295 compounds for research procurement:

    • CJC-1295 No DAC 10mg β€” $60.00
      High-purity CJC-1295 without the Drug Affinity Complex, supplied as lyophilized powder. Ideal for researchers studying pulsatile GH release dynamics in preclinical models. HPLC-verified purity β‰₯98%, with third-party quality assurance available.

    • CJC-1295/Ipamorelin Blend 5mg/5mg β€” $80.00
      A pre-blended combination of CJC-1295 no DAC and Ipamorelin in a single lyophilized vial (5mg each). Designed for researchers exploring dual-pathway GHRH and GHS-R agonism in animal model experiments. Simplifies preparation for combination peptide studies.

    Both products are available for CJC 1295 buy online through the Iron Peak Peptides shop with fast US domestic shipping and full documentation.


    Pricing and Value Considerations for Research Budgets

    Research budgets are finite, and cost-per-milligram is a legitimate procurement considerationβ€”provided it is never prioritized over quality. At $60.00 for 10mg of HPLC-verified CJC-1295 no DAC, Iron Peak Peptides offers competitive pricing relative to peer domestic suppliers without compromising on purity documentation or batch traceability.

    For labs conducting experiments that require the CJC-1295/Ipamorelin combination, the pre-blended 5mg/5mg vial at $80.00 represents meaningful value compared to purchasing each compound separately, while also reducing preparation variables that can affect experimental consistency.

    Researchers should be cautious of unusually low-priced peptides from unfamiliar vendors. Sub-standard purity, absence of quality assurance documentation, and inconsistent batch quality represent far greater costs in the form of failed experiments, wasted reagents, and compromised data integrity.


    Frequently Asked Questions

    Is CJC-1295 legal to buy for research?

    In the United States, CJC-1295 is not a scheduled controlled substance, and it is legal to purchase for legitimate laboratory and preclinical research purposes. It is not approved by the FDA for human use and must not be used in clinical settings or on human subjects outside of properly authorized clinical trial frameworks. Purchasers are responsible for ensuring compliance with all applicable local, state, and federal regulations.

    What is the difference between CJC-1295 and Sermorelin?

    Sermorelin is a synthetic analog of the first 29 amino acids of endogenous GHRH (GHRH 1-29) without the DPP-IV resistant substitutions found in CJC-1295. Preclinical research indicates that CJC-1295 has a notably longer effective half-life in animal models due to these modifications. Researchers studying extended GH stimulation typically favor CJC-1295, while those studying shorter-duration GH pulse kinetics may explore Sermorelin as a comparative compound.

    How should CJC-1295 lyophilized powder be stored?

    Lyophilized CJC-1295 should be stored at -20Β°C in a sealed, moisture-free environment prior to reconstitution. Once reconstituted with bacteriostatic water (standard laboratory practice for peptide research), aliquots should be stored at 4Β°C and used within the timeframe recommended in the accompanying documentation. Researchers should always follow institutional protocols for handling and storage of research peptides.

    What purity level should researchers require?

    For reliable preclinical research, researchers should require a minimum purity of 98% as verified by HPLC. Lower purity compounds introduce uncharacterized impuritiesβ€”potentially including truncated peptide sequences, oxidized variants, or synthesis by-productsβ€”that can confound experimental results and make data difficult to reproduce or publish.

    Does Iron Peak Peptides provide a quality assurance?

    Yes. Iron Peak Peptides provides third-party quality assurance for all products, including HPLC purity data and mass spectrometry confirmation of peptide identity. COAs can be requested prior to or at the time of purchase.

    Can I buy CJC-1295 and Ipamorelin together?

    Yes. Iron Peak Peptides offers a CJC-1295/Ipamorelin Blend (5mg/5mg) as a single pre-formulated lyophilized product, making it a practical option for researchers who want to study both compounds simultaneously without the need to combine separate vials during lab preparation.


    Conclusion: Sourcing CJC-1295 for Serious Research

    For researchers focused on growth hormone axis biology, peptide receptor pharmacology, or preclinical models of GH secretion, CJC-1295 remains one of the most well-characterized and widely studied synthetic GHRH analogs available. The quality of your research, however, is only as good as the quality of your reagents.

    When evaluating where to source this compound, prioritize suppliers who lead with transparency: HPLC data, third-party COAs, clear labeling, lyophilized format, and US-based operations. Iron Peak Peptides meets all of these standards and is committed exclusively to supporting the legitimate scientific research community.

    Ready to source research-grade CJC-1295? Browse the full catalog of verified peptide research compounds at Iron Peak Peptides. All products are for research use only and are not intended for human consumption.

    Disclaimer: All products sold by Iron Peak Peptides are intended for laboratory research use only by licensed professionals. They are not intended for human consumption, self-administration, or therapeutic use. Nothing in this article constitutes medical advice. Researchers are solely responsible for compliance with applicable laws and regulations governing peptide research in their jurisdiction.

    Related Research


    🔬 Explore Research Peptides

    ← Peptide Research Regulation 2025: RFK Jr.’s Push and What It Means for the Research Community
    Where to Buy TB-500 (Thymosin Beta-4) for Research β†’